Kcnq2 mouse models have proven invaluable for elucidating pathological mechanisms, accessing neuronal networks, and evaluating cognitive deficits associated with KCNQ2 epileptic disorders.
This review highlights the utility of Kcnq2 mouse models in elucidating pathological mechanisms and identifying therapeutic targets for KCNQ2-related epileptic disorders.
Variants in the Kv7.2 channel subunit encoded by the KCNQ2 gene cause epileptic disorders ranging from a benign form with self-limited epileptic seizures and normal development to severe forms with intractable epileptic seizures and encephalopathy. The biological mechanisms involved in these neurological diseases are still unclear. The disease remains intractable in patients affected by the severe form. Over the past 20 years, KCNQ2 models have been developed to elucidate pathological mechanisms and to identify new therapeutic targets. The diversity of Kcnq2 mouse models has proven invaluable to access neuronal networks and evaluate the associated cognitive deficits. This review summarizes the available models and their contribution to our current understanding of KCNQ2 epileptic disorders.
Brun et al. (Thu,) conducted a review in KCNQ2 epileptic disorders. Kcnq2 mouse models was evaluated. Kcnq2 mouse models have proven invaluable for elucidating pathological mechanisms, accessing neuronal networks, and evaluating cognitive deficits associated with KCNQ2 epileptic disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: